Clinical Characteristics of Patients with Medically Unexplained Chronic Widespread Pain: A Primary Care Center Study

다국어 초록 (Multilingual Abstract)

Background: Chronic widespread pain (CWP) is known as a common symptom of several organic and psychological disorders. Although medically unexplained CWP (MUE) has lots of clinical distress symptoms, there were no distinct symptoms or signs. Therefore, we conducted this study to investigate clinical distress symptoms of MUE distinct from those of medically explained CWP (ME).
Methods: One hundred nine patients with CWP were enrolled in the study. We classified the study subjects into three groups depending on their medical problems associated with CWP: organic group (ORG), psychological group (PSY),and MUE. All subjects were asked to fi ll out self-report questionnaires consisting of clinical distress scales including the Korean version of the Fibromyalgia Impact Questionnaire (FIQ-K), fatigue scale, depression scale, and stress scale. And physicians examined 18 tender points over their entire body of the subjects.
Results: MUE patients had higher FIQ-K and fatigue severity scores than ORG patients (all P < 0.05). The average number of tender points were 11.33 in MUE patients, 6.48 in ORG patients and 5.02 in PSY patients and statistically signifi cant (P < 0.0001). There were no statistically different factors between MUE and PSY patients with exception for the number of tender points. Depressive symptom was the highest in PSY patients but not statistically different from MUE patients.
Conclusion: MUE patients had higher physical impairments, fatigue severity and more number of tender points than ORG patients, but had no different clinical characteristics from PSY patients except for the number of tender points.

참고문헌 (Reference)

1 MacFarlane GJ, "Widespread pain: is an improved classification possible" 23 : 1628-1632, 1996

2 Yun-AKim, "Validation of a Korean Version of the Fibromyalgia Impact Questionnaire" 대한의학회 17 (17): 220-224, 2002

3 Pae CU, "The relationship between fi bromyalgia and major depressive disorder: a comprehensive review" 24 : 2359-2371, 2008

4 Wolfe F, "The prevalence and characteristics of fi bromyalgia in the general population" 38 : 19-28, 1995

5 Gran JT, "The epidemiology of chronic generalized musculoskeletal pain" 17 : 547-561, 2003

6 Fukuda K, "The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group" 121 : 953-959, 1994

7 Benjamin S, "The association between chronic widespread pain and mental disorder: a population-based study" 43 : 561-567, 2000

8 Wolfe F, "The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia: report of the Multicenter Criteria Committee" 33 : 160-172, 1990

9 Lundberg G, "Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fi bromyalgia syndrome" 29 : 603-613, 2002

10 Yunus MB, "Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain" 21 : 481-497, 2007

11 McBeth J, "Risk factors for persistent chronic widespread pain: a community-based study" 40 : 95-101, 2001

12 Epstein SA, "Psychiatric disorders in patients with fibromyalgia: a multicenter investigation" 40 : 57-63, 1999

13 Raphael KG, "Psychiatric comorbidities in a community sample of women with fi bromyalgia" 124 : 117-125, 2006

14 Makela M, "Prevalence of primary fi bromyalgia in the Finnish population" 303 : 216-219, 1991

15 Bradley LA, "Pathophysiologic mechanisms of fibromyalgia and its related disorders" 69 (69): 6-13, 2008

16 Aaron LA, "Overlapping conditions among patients with chronic fatigue syndrome, fi bromyalgia, and temporomandibular disorder" 160 : 221-227, 2000

17 Hudson JI, "Family study of affective spectrum disorder" 60 : 170-177, 2003

18 McBeth J, "Epidemiology of chronic musculoskeletal pain" 21 : 403-425, 2007

19 Koh KB, "Development of the stress response inventory and its application in clinical practice" 63 : 668-678, 2001

20 Gormsen L, "Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain" 14 (14): e1-e8, 2010

21 Jung KI, "Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression" 9 : 164-173, 2001

22 Anderberg UM, "Citalopram in patients with fibromyalgia: a randomized, doubleblind, placebo-controlled study" 4 : 27-35, 2000

23 Bliddal H, "Chronic widespread pain in the spectrum of rheumatological diseases" 21 : 391-402, 2007

24 Papageorgiou AC, "Chronic widespread pain in the population: a seven year follow up study" 61 : 1071-1074, 2002

25 Macfarlane GJ, "Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior" 26 : 413-419, 1999

26 Kato K, "Chronic widespread pain and its comorbidities: a population-based study" 166 : 1649-1654, 2006

27 Clauw DJ, "Chronic widespread pain and fi bromyalgia: what we know, and what we need to know" 17 : 685-701, 2003

28 White KP, "Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample" 29 : 588-594, 2002

29 Bergman S, "Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study" 28 : 1369-1377, 2001

30 Aaron LA, "Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions" 17 : 563-574, 2003

31 Hahn HM, "A standardization study of beck depression inventory in Korea" 25 : 487-502, 1986

32 Arnold LM, "A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder" 50 : 2974-2984, 2004